NovaGo Therapeutics Company
NovaGo Therapeutics is a biotech start-up company that specializes in developing human antibody therapeutics to treat cerebral stroke and spinal cord injury. The company has a strategic partnership with Neurimmune, which provides access to a unique class of human-derived antibodies with exceptional therapeutic properties generated through their Reverse Translational Medicine\u2122 (RTM\u2122) technology platform. NovaGo Therapeutics was founded in 2015 in Schlieren, Switzerland, and is focused on developing human antibody therapeutics to target nerve growth and regeneration for the treatment of spinal cord injury.
Founded Date:
2015
Headquarters:
Schlieren
Technology:
Antibodies
Employee Number:
1-10
Industry:
BioTech
Estimated Revenue:
$1M to $10M
Total Funding:
CHF10M